IP Library Granted Patent US 11,963,729
Granted Patent B2
US 11,963,729 · App. 17/250,230 · Granted Apr 23, 2024

Artificial intelligence for robotic surgery

Inventors: Nikolai Aljuri (Hillsborough, CA); Surag Mantri (East Palo Alto, CA); Kevin Staid (Lowell, MA)
Assignee: PROCEPT BioRobotics Corporation
A61B34/30A61B34/10A61B2034/104A61B2034/107A61B2034/108
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,963,729
App. No.
17/250,230
Granted
Apr 23, 2024
Kind
B2
Abstract

An apparatus for robotic surgery comprises a processor configured with instructions to receive patient data from treated patients, receive surgical robotics data for each of the plurality of treated patients, and output a treatment plan of a patient to be treated in response to the patient data and the surgical robotics data. This approach has the advantage of accommodating individual variability among patients and surgical system parameters so as to provide improved treatment outcomes.

Claims (35)

1. An apparatus to remove tissue of an organ of a patient, the apparatus comprising:

a display;

a processor operatively coupled to the display, the processor configured with instructions to,

receive one or more of a safety parameter or an efficacy parameter for the patient,

receive an image of the organ,

determine a removal profile of the organ in response to the image and the one or more of the safety parameter or the efficacy parameter, and

display the removal profile with the image on the display;

wherein the processor is configured with instructions to receive a user input to adjust the removal profile shown on the display to generate an adjusted removal profile.

2. The apparatus of claim 1 , wherein the organ comprises a delicate tissue structure and the removal profile comprises a protection zone, and the protection zone of the removal profile is determined in response to the image of the organ and the one or more of the safety parameter or the efficacy parameter.

3. The apparatus of claim 2 , wherein the organ comprises a prostate and the delicate tissue structure comprises a verumontanum of the prostate.

4. The apparatus of claim 2 , wherein the delicate tissue structure comprises cancerous tissue.

5. The apparatus of claim 2 , wherein the protection zone is one of a plurality of protection zones, and the plurality of protection zones of the removal profile are determined, at least in response, to the image of the organ and the one or more of the safety parameter or the efficacy parameter.

6. The apparatus of claim 5 , wherein one or more of the plurality of protection zones are determined, at least in part, based on one or more of avoiding damage to delicate tissue structures or avoiding disbursement of pathogenic tissue.

7. The apparatus of claim 2 , wherein the image of the organ is shown on the display with the removal profile in a sagittal view and a transverse view, and the removal profile comprises a three-dimensional volumetric removal profile.

8. The apparatus of claim 2 , wherein the processor is configured with instructions to display the image of the organ with the removal profile in one or more of a sagittal view, parasagittal view, a transverse view, a coronal view, a paracoronal view, or a three-dimensional view.

9. The apparatus of claim 8 , wherein the processor is configured with instructions to display the safety parameter and the efficacy parameter on the display.

10. The apparatus of claim 8 , wherein the processor is configured to determine a second value of the one or more of the safety parameter or the efficacy parameter on the display in response to the user adjusted removal profile.

11. The apparatus of claim 1 , wherein the processor is configured with instructions to display the safety parameter and the efficacy parameter on the display.

12. The apparatus of claim 1 , wherein the processor is configured with instructions to display a value of a target safety parameter, a value of a target efficacy parameter, an adjusted safety parameter and an adjusted efficacy parameter, wherein the adjusted safety parameter and the adjusted efficacy parameter are updated in real time and shown on the display in response to the user adjusting the removal profile.

13. The apparatus of claim 1 , wherein the organ comprises a prostate and the processor is configured with instructions to identify a location of a verumontanum of the prostate.

14. The apparatus of claim 1 , wherein the image of the organ comprises one or more of tissue margin identification, tissue plane identification, tissue differentiation detection, fluoroscopy, CT scan imaging, magnetic resonance imaging, radioactivity detection, or radiopaque imaging.

15. An apparatus to remove tissue of an organ of a patient, the apparatus comprising:

a display;

a processor operatively coupled to the display, the processor configured with instructions to,

receive an image of the organ,

receive a removal profile of the organ, and

display a value of one or more of a safety parameter or an efficacy parameter in response to the removal profile and the image,

wherein the processor is configured with instructions to receive a user input to adjust the removal profile shown on the display to generate an adjusted removal profile and determine a second value of the one or more of the safety parameter or the efficacy parameter on the display in response to the user adjusted removal profile.

16. The apparatus of claim 15 , wherein the organ comprises a delicate tissue structure and the processor is configured with instructions to determine a location of the delicate tissue structure in relation to the removal profile and to display the value of the one or more of the safety parameter or the efficacy parameter in response to the location of the delicate tissue structure and the removal profile.

17. The apparatus of claim 16 , wherein the organ comprises a prostate and the delicate tissue structure comprises a verumontanum of the prostate.

18. The apparatus of claim 16 , wherein the delicate tissue structure comprises cancerous tissue.

19. The apparatus of claim 16 , wherein the removal profile comprises one or more protection zones determined, at least in part, based upon one or more of decreasing damage to the delicate tissue structure or avoiding disbursement of pathogenic tissue.

20. The apparatus of claim 15 , wherein the image of the organ is shown on the display with the removal profile in a sagittal view and a transverse view, and the removal profile comprises a three dimensional volumetric removal profile.

21. The apparatus of claim 15 , wherein the processor is configured with instructions to display the image of the organ overlaid with the removal profile in a sagittal view and a transverse view.

22. The apparatus of claim 21 , wherein the processor is configured with instructions to display the safety parameter and the efficacy parameter on the display.

Assignments (3)
SECURITY INTEREST Recorded Oct 6, 2022
From: PROCEPT BIOROBOTICS CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061623/0289 →
MERGER Recorded Apr 14, 2021
From: PROCEPT BIOROBOTICS CORPORATION
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 055941/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2021
From: ALJURI, NIKOLAI; MANTRI, SURAG; STAID, KEVIN
To: PROCEPT BIOROBOTICS CORPORATION
Reel/Frame 054874/0889 →
Continuity (2)
Provisional Application 62688349 · Jun 21, 2018
Related Publication 20210121251A1 · Apr 29, 2021
Cited By (7)
US 12,324,641 US 12,496,137 US 12,636,082 US 12,648,815 US 12,661,133 US 12,678,173 US 12,702,484